Health TrialsbyHealthPanel

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Evaluate the Safety, Tolerability and PK of SK-09

This Phase 1 trial consists of three parts: Part 1 is a Single Ascending Dose (SAD) study, Part 2 is a Multiple Ascending Dose (MAD) study. Both parts adopt a randomized, double-blind, placebo-controlled design. Part 3 is a randomized, open-label, single-dose, two-period crossover self-controlled design FE study.

Participants needed: 84
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Consun Pharmaceutical GroupUpdated: Sep 3, 2026Locations: 1
Eligibility criteria

Healthy male and female participants aged 18 to 55 years (inclusive) at the time... [+3]

History or current presence of clinically significant Cardiovascular; Respirator... [+19]

Read more
Status: Recruiting

A Study to Evaluate the Safety, Tolerability and PK of SK-08

The trial is conducted in a single-center, randomized, double-blind, placebo-controlled, dose-increasing design. To evaluate the safety, tolerability, pharmacokinetics(PK) ,and pharmacodynamics (PD) characteristics of SK-08 in healthy participants.

Participants needed: 48
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Consun Pharmaceutical GroupUpdated: Jun 24, 2025Locations: 1
Eligibility criteria

Healthy male and female participants aged 18 to 45 years (inclusive). [+3]

Have a specific history of allergies or have an allergic constitution； [+12]

Read more